array(57) { ["SERVER_SOFTWARE"]=> string(6) "Apache" ["REQUEST_URI"]=> string(42) "/instituto/idorpost_scientists/paulo-hoff/" ["PHP_PATH"]=> string(24) "/opt/bitnami/php/bin/php" ["FREETDSLOCALES"]=> string(0) "" ["FREETDSCONF"]=> string(0) "" ["OPENSSL_ENGINES"]=> string(31) "/opt/bitnami/common/lib/engines" ["OPENSSL_CONF"]=> string(39) "/opt/bitnami/common/openssl/openssl.cnf" ["SSL_CERT_FILE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["CURL_CA_BUNDLE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["LDAPCONF"]=> string(42) "/opt/bitnami/common/etc/openldap/ldap.conf" ["GS_LIB"]=> string(43) "/opt/bitnami/common/share/ghostscript/fonts" ["MAGICK_CODER_MODULE_PATH"]=> string(60) "/opt/bitnami/common/lib/ImageMagick-6.9.8/modules-Q16/coders" ["MAGICK_CONFIGURE_PATH"]=> string(73) "/opt/bitnami/common/lib/ImageMagick-6.9.8/config-Q16:/opt/bitnami/common/" ["MAGICK_HOME"]=> string(19) "/opt/bitnami/common" ["PATH"]=> string(260) "/opt/bitnami/apps/wordpress/bin:/opt/bitnami/varnish/bin:/opt/bitnami/sqlite/bin:/opt/bitnami/php/bin:/opt/bitnami/mysql/bin:/opt/bitnami/letsencrypt/:/opt/bitnami/apache2/bin:/opt/bitnami/common/bin:/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin" ["USER"]=> string(6) "daemon" ["HOME"]=> string(9) "/usr/sbin" ["SCRIPT_NAME"]=> string(10) "/index.php" ["QUERY_STRING"]=> string(0) "" ["REQUEST_METHOD"]=> string(3) "GET" ["SERVER_PROTOCOL"]=> string(8) "HTTP/1.0" ["GATEWAY_INTERFACE"]=> string(7) "CGI/1.1" ["REDIRECT_URL"]=> string(42) "/instituto/idorpost_scientists/paulo-hoff/" ["REMOTE_PORT"]=> string(5) "58128" ["SCRIPT_FILENAME"]=> string(44) "/opt/bitnami/apps/wordpress/htdocs/index.php" ["SERVER_ADMIN"]=> string(15) "you@example.com" ["CONTEXT_DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["CONTEXT_PREFIX"]=> string(0) "" ["REQUEST_SCHEME"]=> string(4) "http" ["DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["REMOTE_ADDR"]=> string(12) "52.67.79.103" ["SERVER_PORT"]=> string(2) "80" ["SERVER_ADDR"]=> string(13) "172.26.13.183" ["SERVER_NAME"]=> string(13) "54.225.48.228" ["SERVER_SIGNATURE"]=> string(0) "" ["LD_LIBRARY_PATH"]=> string(410) "/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/varnish/lib:/opt/bitnami/varnish/lib/varnish:/opt/bitnami/varnish/lib/varnish/vmods:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/common/lib64" ["HTTP_ACCEPT_ENCODING"]=> string(7) "br,gzip" ["HTTP_VIA"]=> string(64) "1.1 f9efe5e72b7e5cc47bf34a0b0debcbe2.cloudfront.net (CloudFront)" ["HTTP_X_AMZ_CF_ID"]=> string(56) "qmEkhjdpLcXJxVIrH37xmOQrR5MdohRE79Jqe4Ze3jIu8LC8AlBpVA==" ["HTTP_USER_AGENT"]=> string(17) "Amazon CloudFront" ["HTTP_X_AMZN_TRACE_ID"]=> string(40) "Root=1-62828f2f-3fd956120d26808b77250b65" ["HTTP_X_FORWARDED_PORT"]=> string(2) "80" ["HTTP_CONNECTION"]=> string(5) "close" ["HTTP_X_FORWARDED_PROTO"]=> string(4) "http" ["HTTP_X_FORWARDED_FOR"]=> string(39) "34.231.247.88, 64.252.69.123, 10.0.0.57" ["HTTP_X_REAL_IP"]=> string(9) "10.0.0.57" ["HTTP_X_FORWARDED_HOST"]=> string(25) "www.rededorsaoluiz.com.br" ["HTTP_HOST"]=> string(13) "54.225.48.228" ["SCRIPT_URI"]=> string(62) "http://54.225.48.228/instituto/idorpost_scientists/paulo-hoff/" ["SCRIPT_URL"]=> string(42) "/instituto/idorpost_scientists/paulo-hoff/" ["REDIRECT_STATUS"]=> string(3) "200" ["REDIRECT_SCRIPT_URI"]=> string(62) "http://54.225.48.228/instituto/idorpost_scientists/paulo-hoff/" ["REDIRECT_SCRIPT_URL"]=> string(42) "/instituto/idorpost_scientists/paulo-hoff/" ["FCGI_ROLE"]=> string(9) "RESPONDER" ["PHP_SELF"]=> string(10) "/index.php" ["REQUEST_TIME_FLOAT"]=> float(1652723503.6489) ["REQUEST_TIME"]=> int(1652723503) }

Paulo Hoff

Paulo Hoff

Pesquisa

Minha linha de pesquisa inclui o desenvolvimento de novas terapias para tratamento de tumores gastrointestinais.

Palavras-chave: Adenocarcinoma de cólon, adenocarcinoma de reto, tumores neuroendocrinos, tumores de pâncreas, tumores de trato gastrointestinal alto

PESQUISA

Pós doutorado clínico em hematologia e oncologia pela universidade do texas – md anderson cancer center

Doutor em medicina pela universidade de são paulo

Professor titular de oncologia clínica da universidade de são paulo

ÁREAS DE PESQUISA

INFORMAÇÕES ADICIONAIS

Prêmios e Títulos

Professor do ano do md anderson cancer center da universidade do texas (2000)

Prêmio jabuti – c mara brasileira do livro – abl 56º edição (2014)

Membro titular da academia nacional de medicina (2017-presente).

Fasco - fellow of the american society of clinical oncology - reconhecimento aos membros da asco, extraordinário serviço voluntário, dedicação e compromisso. os esforços em prol da especialidade, asco - annual meeting 2018- chicago.

Primeiro brasileiro a ser eleito para um cargo no conselho diretor da american society of clinical oncology (asco), organização que representa oncologistas no mundo, de 2013 a 2018.

Publicações Selecionadas

Claret L, Girard P, Hoff PM, Van Cutsem E, Zuideveld KP, Jorga K, Fagerberg J, Bruno R. Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics. J Clin Oncol. 2009 Sep 1;27(25):4103-8. Epub 2009 Jul 27. PMID: 19636014.

Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4147-53. PMID: 16857785.

Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006 May 1;24(13):2065-72. doi: 10.1200/JCO.2005.05.3074. PMID: 16648507

Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO, Wong R. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol. 2001 Apr 15;19(8):2282-92.

H.J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, B. Nordlinger, C.J. van de Velde, J. Balmana, J. Regula, I.D. Nagtegaal, R.G. Beets-Tan, D. Arnold, F. Ciardiello, P. Hoff, D. Kerr, C.H. Köhne, R. Labianca, T. Price, W. Scheithauer, A. Sobrero, J. Tabernero, D. Aderka, S. Barroso, G. Bodoky, J.Y. Douillard, H. El Ghazaly, J. Gallardo, A. Garin, R. Glynne-Jones, K. Jordan, A. Meshcheryakov, D. Papamichail, P. Pfeiffer, I. Souglakos, S. Turhal, A. Cervantes,
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making, Annals of Oncology, Volume 23, Issue 10, 2012, Pages 2479-2516, ISSN 0923-7534.

Notícias Relacionadas
Conteúdo Relacionado